Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt
about
Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcriptionEnzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promotersAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityResveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterasesSIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cellsBiochemical effects of SIRT1 activatorsCalorie restriction and the exercise of chromatinCircadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesisCancer Clocks Out for Lunch: Disruption of Circadian Rhythm and Metabolic Oscillation in CancerRegulation and function of AMPK in physiology and diseasesEmerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disordersSIRT1: A Novel Target for the Treatment of Muscular DystrophiesDiabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3Erythropoietin and diabetes mellitusDysregulated metabolism contributes to oncogenesisProtective effects and mechanisms of sirtuins in the nervous systemRegulation of satellite cell function in sarcopeniaSIRT1 as a therapeutic target in inflammaging of the pulmonary diseaseTargeting sirtuin 1 to improve metabolism: all you need is NAD(+)?The role of mammalian sirtuins in the regulation of metabolism, aging, and longevityNAD+ as a signaling molecule modulating metabolismMetabolic reprogramming as a novel regulator of skeletal muscle development and regenerationRegulation of cell survival and death by pyridine nucleotidesUndercover: gene control by metabolites and metabolic enzymesFrom Nutrient to MicroRNA: a Novel Insight into Cell Signaling Involved in Skeletal Muscle Development and DiseaseNew Insights for Oxidative Stress and Diabetes MellitusLongevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intakeA human tRNA synthetase is a potent PARP1-activating effector target for resveratrolSirtuin deacylases: a molecular link between metabolism and immunitySlowing ageing by design: the rise of NAD(+) and sirtuin-activating compoundsMitochondrial dysfunction in neurodegenerative diseasesThe physiological roles of Sirt1 in skeletal muscleThe effects of obesity on skeletal muscle regenerationWld(S) reduces paraquat-induced cytotoxicity via SIRT1 in non-neuronal cells by attenuating the depletion of NADReversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencingCilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal CellsNitrite activates AMP kinase to stimulate mitochondrial biogenesis independent of soluble guanylate cyclaseAMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscleA potent and selective small molecule inhibitor of sirtuin 1 promotes differentiation of pluripotent P19 cells into functional neuronsRegulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle
P2860
Q21296795-C9CF5283-3D5D-42A9-B8D4-E7948A7A9653Q24314812-F1D136A8-F8C7-409D-9428-3A9CAE08D29FQ24595845-95D49C19-296D-4D76-BBDE-A48B87843646Q24608197-D587F5CA-7DAC-4679-9CAD-62EA36185BE7Q24633565-A4FFFA22-9EBE-494E-BAC3-32D3D3066254Q24633830-858DD09F-9DE1-4575-80EF-D35E0BCD43C9Q24652611-AE9FFEFA-F653-4D56-BA1B-E07552F41334Q24658408-2EE8CC47-60BC-4D27-9E43-F4940CC0F36CQ26738550-DE22ECC4-6664-40B0-9BA9-9DFFF6FF3679Q26740291-04778A4C-9DD6-44D1-8C39-5EE65CEA3FE0Q26741300-1E944047-A31F-497E-AB79-4A2568AC69FDQ26748736-1BC4EEB5-DBC8-4CED-822A-EA38B07519C9Q26749486-964EF136-B009-4FF1-9D8C-A135D042244BQ26777878-6A10DB3F-4AED-456F-9CC1-569ADB2E5060Q26784630-7053B1AC-4991-4843-B0D7-E585C8AAD322Q26825585-D92E29ED-4DDA-489D-BC59-1BD907F1F23DQ26826890-4D9C3ED1-C3D2-478A-83BF-391E901534D6Q26829351-82D0FDE5-6C66-4146-939A-8C17338C5ED4Q26864685-28160870-0426-4BF2-A9B3-960B6C456ED1Q26865526-A6503D7A-7780-45D4-8B7F-DCA462F09911Q26995735-A42B5D68-D0AD-4A03-833F-5AE2E65370BDQ27002421-CE6F4B36-B7B4-4FA5-9DFA-C75C04B54E7EQ27026075-65B22206-3518-4CA6-A64E-3FA249D4B0B5Q28072281-C3915CF4-1415-4555-A399-7FC9CDDE8889Q28080060-6DC2FC3E-80BE-497D-9F73-E0508EACA1ABQ28080679-1AB3B353-BF9C-47F4-AC84-277A2B52F35CQ28083422-427BD345-DBE2-424F-8FCB-EA4574C3A8C0Q28254419-3E7A2C65-F0C3-41AB-AE16-30EA7E930877Q28283588-0F3D343F-4136-4189-AA79-7F9F7F0F8925Q28314993-0DA16705-2DA7-481E-8B79-3C972C45549FQ28387647-954441E7-A506-47C3-9FA0-2CBA691A33CCQ28389469-8EF68A14-DEED-4B79-91FB-EFE4FB17AE15Q28393087-3E724051-C954-4954-B8B7-060BDA219100Q28478925-459F82AD-2601-4C4E-974C-37717C07F41DQ28508559-EA6BAB1F-6C4B-4ECC-A116-E75BBE5E4B1CQ28553396-8AA8BF1F-36F0-4B1D-84DB-C0FB2E2A0B58Q28579907-6AD6A97D-A0A9-4B50-BC72-A2B0F11C9AD3Q28592195-E8BCB79A-BF55-4804-94A0-FA957CD443BDQ28828567-84875370-E685-4E61-854B-929F2A8B3665Q30428955-C3E47920-238F-4305-8E43-9B28ADFDF849
P2860
Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Glucose restriction inhibits s ...... K-mediated regulation of Nampt
@ast
Glucose restriction inhibits s ...... K-mediated regulation of Nampt
@en
type
label
Glucose restriction inhibits s ...... K-mediated regulation of Nampt
@ast
Glucose restriction inhibits s ...... K-mediated regulation of Nampt
@en
prefLabel
Glucose restriction inhibits s ...... K-mediated regulation of Nampt
@ast
Glucose restriction inhibits s ...... K-mediated regulation of Nampt
@en
P2093
P2860
P1433
P1476
Glucose restriction inhibits s ...... K-mediated regulation of Nampt
@en
P2093
Anthony A Sauve
Eric P Hoffman
Marcella Fulco
Michael W McBurney
P2860
P304
P356
10.1016/J.DEVCEL.2008.02.004
P407
P577
2008-05-01T00:00:00Z